These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 18293237)

  • 41. Recruitment and follow-up of injecting drug users in the setting of early hepatitis C treatment: insights from the ATAHC study.
    Nguyen OK; Dore GJ; Kaldor JM; Hellard ME;
    Int J Drug Policy; 2007 Oct; 18(5):447-51. PubMed ID: 17854736
    [TBL] [Abstract][Full Text] [Related]  

  • 42. HIV, hepatitis C virus, and hepatitis B virus co-infections among injecting drug users in Tehran, Iran.
    Rahimi-Movaghar A; Razaghi EM; Sahimi-Izadian E; Amin-Esmaeili M
    Int J Infect Dis; 2010 Jan; 14(1):e28-33. PubMed ID: 19464218
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Integrating multiple programme and policy approaches to hepatitis C prevention and care for injection drug users: a comprehensive approach.
    Birkhead GS; Klein SJ; Candelas AR; O'Connell DA; Rothman JR; Feldman IS; Tsui DS; Cotroneo RA; Flanigan CA
    Int J Drug Policy; 2007 Oct; 18(5):417-25. PubMed ID: 17854731
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Epidemiological and genetic analyses of Hepatitis C virus transmission among young/short- and long-term injecting drug users from Rio de Janeiro, Brazil.
    Oliveira Mde L; Bastos FI; Telles PR; Hacker Mde A; Oliveira SA; Miguel JC; Yoshida CF
    J Clin Virol; 2009 Mar; 44(3):200-6. PubMed ID: 19195927
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Illegal drug users and risk factors for HIV and HCV infection].
    Backmund M
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2007 Apr; 50(4):471-5. PubMed ID: 17377722
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prevalence, incidence and risk factors for hepatitis C in homosexual men: data from two cohorts of HIV-negative and HIV-positive men in Sydney, Australia.
    Jin F; Prestage GP; Matthews G; Zablotska I; Rawstorne P; Kippax SC; Kaldor JM; Grulich AE
    Sex Transm Infect; 2010 Feb; 86(1):25-8. PubMed ID: 19841001
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Gender differences in HIV risk behaviours among intravenous drug users in Catalonia, Spain.
    Folch C; Casabona J; Espelt A; Majó X; Meroño M; Gonzalez V; Brugal MT;
    Gac Sanit; 2013; 27(4):338-43. PubMed ID: 23578527
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The influence of needle exchange programs on injection risk behaviors and infection with hepatitis C virus among young injection drug users in select cities in the United States, 1994-2004.
    Holtzman D; Barry V; Ouellet LJ; Des Jarlais DC; Vlahov D; Golub ET; Hudson SM; Garfein RS
    Prev Med; 2009 Aug; 49(1):68-73. PubMed ID: 19410600
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Needle exchange use, sexual risk behaviour, and the prevalence of HIV, hepatitis B virus, and hepatitis C virus infections among Bulgarian injection drug users.
    Vassilev ZP; Hagan H; Lyubenova A; Tomov N; Vasilev G; Krasteva D; Des Jarlais DC
    Int J STD AIDS; 2006 Sep; 17(9):621-6. PubMed ID: 16942654
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Incidence of hepatitis C virus infection among injection drug users during an outbreak of HIV infection.
    Patrick DM; Tyndall MW; Cornelisse PG; Li K; Sherlock CH; Rekart ML; Strathdee SA; Currie SL; Schechter MT; O'Shaughnessy MV
    CMAJ; 2001 Oct; 165(7):889-95. PubMed ID: 11599327
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The impact of injecting drug use status on hepatitis C-related referral and treatment.
    Stoové MA; Gifford SM; Dore GJ
    Drug Alcohol Depend; 2005 Jan; 77(1):81-6. PubMed ID: 15607844
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The investigation of HIV and HCV infection and risk factors among opiate drug users in Beijing, China.
    Bao YP; Du C; Lu HY; Lian Z; Qiu Y; Mu Y; Yan SY; Liu ZM
    Am J Drug Alcohol Abuse; 2012 Mar; 38(2):140-5. PubMed ID: 22175771
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Type and location of injection drug use-related soft tissue infections predict hospitalization.
    Takahashi TA; Merrill JO; Boyko EJ; Bradley KA
    J Urban Health; 2003 Mar; 80(1):127-36. PubMed ID: 12612102
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Public Health Approaches Toward Eliminating Hepatitis C Virus in Rhode Island.
    Murphy M; Howe K; Marak T; Bertrand T; Maynard M; Ndoye CD; Joseph R; Fingerut J; Chan PA
    R I Med J (2013); 2020 Jun; 103(5):22-25. PubMed ID: 32481775
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Injection drug users: hospital care and charges.
    Stein MD; Sobota M
    Drug Alcohol Depend; 2001 Sep; 64(1):117-20. PubMed ID: 11470348
    [TBL] [Abstract][Full Text] [Related]  

  • 56. HCV among The Miriam Hospital and Rhode Island Hospital Adult ED Patients.
    Merchant RC; Baird JR; Liu T; Taylor LE
    R I Med J (2013); 2014 Jul; 97(7):35-9. PubMed ID: 24983020
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Estimating the true prevalence of hepatitis C in rhode island.
    Kinnard EN; Taylor LE; Galárraga O; Marshall BD
    R I Med J (2013); 2014 Jul; 97(7):19-24. PubMed ID: 24983016
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Skin and needle hygiene intervention for injection drug users: results from a randomized, controlled Stage I pilot trial.
    Phillips KT; Stein MD; Anderson BJ; Corsi KF
    J Subst Abuse Treat; 2012 Oct; 43(3):313-21. PubMed ID: 22341554
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Development of a risk reduction intervention to reduce bacterial and viral infections for injection drug users.
    Phillips KT; Altman JK; Corsi KF; Stein MD
    Subst Use Misuse; 2013 Jan; 48(1-2):54-64. PubMed ID: 23017057
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Bacterial infections in people who inject psychoactive substances: An observational study in a French university hospital.
    Roy S; Eiden C; Xatart S; Soler M; Faucherre V; Picot MC; Reynes J; Donnadieu-Rigole H; Peyrière H
    Therapie; 2021; 76(6):539-547. PubMed ID: 34183194
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.